fistula/tyrosine

Веза се чува у привремену меморију

Изаберите тип сортирања

Страна 1 од 48 резултати

Aerodigestive fistula formation as a rare side effect of antiangiogenic tyrosine kinase inhibitor therapy for thyroid cancer.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND In the past decade, targeted therapy with antiangiogenic drugs has become standard of care for most types of metastatic, progressive thyroid cancer. While these drugs were thought initially to be less toxic than traditional chemotherapy, they can have rare but serious and fatal

[Aerodigestive fistula formation in antiangiogenic tyrosine kinase inhibitor therapy].

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Refractory Renal Cell Cancer with Gastro-renal Fistula: A Rare Complication.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Metastatic renal cell cancer is treated with systemic therapy, and cytoreductive nephrectomy can be offered in selected patients. The systemic therapy treatment options for kidney cancer have now expanded to include tyrosine kinase inhibitors, monoclonal antibodies, immunotherapy, and combinations

Rectovaginal fistula during treatment with axitinib in a patient with renal cell carcinoma: a case report and review of the literature.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Renal cell carcinoma (RCC) is one of the most frequent malignancies of the adults. Its incidence has been increasing steadily by 2-4% each year. Up to 30% of patients present with metastases at diagnosis. It is a highly vascularized cancer because of the hypoxia-induced factor stabilization as a

Bronchopleural fistula in squamous cell lung cancer following anlotinib treatment: A case report.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Anlotinib is a multi-target tyrosine kinase inhibitor and has been approved for the treatment of patients with advanced non-small cell lung cancer. The most common adverse events of this treatment include hypertension, fatigue, thyroid-stimulating hormone elevation, hypertriglyceridemia, hand-foot

Bronchial fistula associated with sunitinib in a patient previously treated with radiation therapy.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

OBJECTIVE To report a case of bronchial fistula associated with sunitinib in a patient previously treated with radiation therapy. METHODS A 40-year-old man with renal cell cancer diagnosed in 2005 and initially treated by radical nephrectomy presented in March 2007 with a recurrence with cerebral,

Bronchial Fistula: Rare Complication of Treatment with Anlotinib

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Background: Anlotinib is a newly developed small molecule multiple receptor tyrosine kinase (RTK) inhibitor that was approved for the treatment of patients with lung cancer in China. We aim to report 3 cases of rare complication of

A case-control study of tyrosine phosphatase (PTPN22) confirms the lack of association with Crohn's disease.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

In Crohn's disease (CD), the whole gastrointestinal tract can be affected by discontinuous and transmural inflammation. The terminal ileum and colon are especially prone to inflammation that comprises granulomata and later intestinal and perianal fistulas. Genome-wide linkage and epidemiological

Tyrosine Kinase Inhibitor Use and Wound Healing in Tracheoesophageal Punctures.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Tyrosine kinase inhibitors (TKIs) aid in prolonging life in patients with advanced locoregional thyroid malignancy. Such patients may undergo total laryngectomy for local disease control and tracheoesophageal puncture (TEP) for speech rehabilitation. Enlargement of TEP fistulas is usually attributed

Tumour-bowel fistula as a possible complication of pazopanib therapy in retroperitoneal leiomyosarcoma.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Pazopanib is a vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR TKI) that inhibits the vascular endothelial growth factor receptor A pathway and has the potential to cause ischaemic bowel changes, including perforation. Here we report a case of a 51-year-old man with

Management of an enterocutaneous fistula in a patient with a gastrointestinal stromal tumor.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

BACKGROUND Gastrointestinal stromal (GIS) tumors are rare malignancies that affect the esophagus, stomach, gallbladder, liver, small intestine, colon, or rectum. These tumors are often refractory to treatment with radiotherapy and chemotherapy and usually treated with a combination of surgery and

Gastropharyngeal Anastomotic Leak in Medullary Thyroid Carcinoma Following Initiation of a Tyrosine Kinase Inhibitor: A Case Report of an Unusual Side Effect of Cabozantinib.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Medullary thyroid carcinoma (MTC) accounts for 1% to 2% of thyroid cancers in the United States. When identified early, total thyroidectomy is most often curative. However, in advanced disease, more aggressive treatment such as laryngectomy and esophagectomy may be indicated.

Angiosarcoma in an arteriovenous fistula after kidney transplantation: Case report and review of treatment options

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

We present a patient with an angiosarcoma in an arteriovenous fistula and we reviewed current treatments for angiosarcomas. We extended the systematic review by Oskrochi et al. on this topic in 2015, using the same search query. We searched systematically OVID, EMBASE and PubMed from April 2015

Pneumothorax triggered by EGFR-tyrosine kinase inhibitors in three microwave ablation candidates: A review of the literature.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are widely used in patients with EGFR-mutant lung cancer. Meanwhile, thermal ablation such as microwave ablation has been an option for selected patients. Herein, we describe three cases of pneumothorax that occurred in

Esophago-tracheobronchial fistula following treatment of anlotinib in advanced squamous cell lung cancer: Two case reports.

Само регистровани корисници могу преводити чланке

Пријави се / Пријави се

Anlotinib, a novel orally administered multitargeted tyrosine kinase inhibitor, inhibiting tumor angiogenesis and growth, significantly prolonged overall survival, and progression-free survival with a manageable safety profile as a third-line therapy among refractory advanced nonsmall

Претходна
1
2
3
4
Следећи

Придружите се нашој
facebook страници

Herbal & Natural Medicine

Најкомплетнија база лековитог биља подржана науком

Ради на 55 језика
Биљни лекови потпомогнути науком
Препознавање биљака по слици
Интерактивна ГПС мапа - означите биље на локацији (ускоро)
Читајте научне публикације повезане са вашом претрагом
Претражите лековито биље по њиховим ефектима
Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима